<DOC>
	<DOCNO>NCT01048606</DOCNO>
	<brief_summary>Menopause characterize decrease estrogen progesterone level associate various change body composition , include accumulation total fat mass , relocation adiposity abdomen , deterioration plasma lipid profile , increase risk type 2 diabetes , increase oxidative stress . Taken together , change increase risk develop cardiovascular disease ( CVD ) . Physical activity hormone-replacement therapy ( HRT ) show act synergy improve total fat mass postmenopausal ( PM ) woman . Because progesterone component HRT associate increase CVD risk old woman family history CVD , use HRT become controversial . As result , large decrease use HRT community observe postmenopausal woman ( PM ) develop interest alternative therapy . Among possibility , phytoestrogens show beneficial effect menopausal symptom plasma lipid . Phytoestrogens structurally functionally similar estradiol ( major estrogen human ) find plant soybean isoflavones . They exert effect breast cancer or/and endometrial tissue . AIMS To examine effect phytoestrogens , exercise combination lean body mass , total fat mass , visceral fat , blood lipid profile , oxidative stress marker , antioxidant system , glucose metabolism , sex-hormone level obese PM woman . HYPOTHESES Women undergo combination phytoestrogen treatment exercise program display great increase lean body mass , decrease total visceral fat mass , improvement blood lipid profile , decrease oxidative stress marker , increase antioxidant system , improvement glucose metabolism , increase sex-hormone level submit one treatment . A total 120 woman recruit . There 4 group ( 30 women/group ) undergo exercise supplement phytoestrogens placebo . The intervention plan last 12 mo . Key variable measure baseline , 6 12 mo intervention . Three weekly 1h-sessions exercise hold 3 non-consecutive day . The phytoestrogen supplement consist 70 mg/d soy isoflavones take 4 caps/day .</brief_summary>
	<brief_title>Exercise Phytoestrogens : Effect Factors Predisposing Cardiovascular Disease ( CVD ) Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Phytoestrogens</mesh_term>
	<criteria>5070 year francophone understand French body mass index &gt; 27kg/mÂ² without physical disability without medical treatment influence metabolism non smoker light drinker ( &lt; 15 g ethanol/day = 1 alcoholic beverage ) weight stable ( &lt; 2 kg ) 6 mo participation supervise exercise program 6 mo without HRT least 3 yr without menses least 12 mo soy allergy know hepatic disease asthma family history accident cerebrovascular personal history feminine cancer</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Postmenopause</keyword>
	<keyword>Overweight</keyword>
	<keyword>Women</keyword>
	<keyword>Phytoestrogens</keyword>
	<keyword>Exercise</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Risk Factors</keyword>
	<keyword>Aging</keyword>
</DOC>